Task: Answer the multiple-choice question.
Question: Which drug exhibits a -12.534% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
(a) Cc1ccc(C)c(-n2c3nc(=O)n(C)c(=O)c-3cc3ccccc32)c1
(b) Cn1c(/C(C#N)=C2/CCCCCN2)nc2ccccc21
(c) CCOC(=O)CSCc1nc(-c2ccc(Cl)cc2)oc1C
(d) CCc1ccccc1NC(=O)CCS(=O)(=O)c1ccc(Br)cc1
Answer: b. Cn1c(/C(C#N)=C2/CCCCCN2)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c(/C(C#N)=C2/CCCCCN2)nc2ccccc21
Cn1c(/C(C#N)=C2/CCCCCN2)nc2ccccc21
(2Z)-2-(azepan-2-ylidene)-2-(1-methylbenzimidazol-2-yl)acetonitrile